FDG PET/CT for early prediction of response to neoadjuvant therapy in HER2+breast cancer: validation in a multicentric population

被引:0
|
作者
Tisserand, S. [1 ]
Kanoun, S. [1 ]
Blanc, J. [1 ]
Coudert, B. [1 ]
Berriolo-Riedinger, A. [1 ]
Cachin, F. [2 ]
Champion, L. [3 ]
Humbert, O. [4 ]
Salaun, P. [5 ]
Mognetti, T. [6 ]
Kerrou, K. [7 ]
机构
[1] Ctr Georges Francois Leclerc, Dijon, France
[2] Ctr Jean Perrin, Clermont Ferrand, France
[3] Inst Curie, Paris, France
[4] Ctr Antoine Lacassagne, Nice, France
[5] CHU Morvan, Brest, France
[6] Ctr Leon Berard, Lyon, France
[7] Hop Tenon, Paris, France
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EPS-009
引用
收藏
页码:S305 / S306
页数:2
相关论文
共 50 条
  • [1] FDG-PET/CT for early prediction of response to neoadjuvant anti-HER2 therapies in HER2-positive breast cancer (BC) patients
    Gebhart, Geraldine
    Flamen, Patrick
    Robles Barba, Javier
    Holmes, Eileen
    Garcia, Camilo
    Cortes Romera, Montserrat
    Eidtmann, Holger
    Baselga, Jose
    Gamez Cenzano, Cristina
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [2] Using neoadjuvant therapy response to guide adjuvant therapy in HER2+breast cancer
    Krop, I.
    [J]. BREAST, 2019, 44 : S13 - S13
  • [3] 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
    Joan Duch
    David Fuster
    Montserrat Muñoz
    Pedro Luís Fernández
    Pilar Paredes
    Montserrat Fontanillas
    Flavia Guzmán
    Sebastià Rubí
    Francisco Juan Lomeña
    Francesca Pons
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1551 - 1557
  • [4] 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
    Duch, Joan
    Fuster, David
    Munoz, Montserrat
    Luis Fernandez, Pedro
    Paredes, Pilar
    Fontanillas, Montserrat
    Guzman, Flavia
    Rubi, Sebastia
    Juan Lomena, Francisco
    Pons, Francesca
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (10) : 1551 - 1557
  • [5] The Pathological Response of Her2+Breast Cancer with Neoadjuvant Chemotherapy and Radiation Therapy
    Chao, M.
    Baker, C.
    Jassal, S.
    Law, M.
    Bevington, E.
    Stoney, D.
    Zantuck, N.
    Chew, G.
    Loh, S. W.
    Hyett, A.
    Guerrieri, M.
    Ng, M.
    Cokelek, M.
    Neoh, D.
    Yong, C.
    Ho, H.
    Tacey, M.
    Joon, D. Lim
    Khor, R.
    Foroudi, F.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E17 - E17
  • [6] Value of 18FDG PET for prediction of therapeutic response in HER2+breast cancer: Interim analysis
    Chanchou, M.
    Mouret-Reynier, M-A
    Cougoul, A.
    Deshayes, E.
    D'Hondt, V
    Bourahla, K.
    Petit, T.
    Bardet, S.
    Levy, C.
    Morel, O.
    Augereau, P.
    Rousseau, C.
    Campone, M.
    Monteil, J.
    Venat-Bouvet, L.
    Benavent, V
    Cachin, F.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2020, 44 (03): : 181 - 188
  • [7] Fdg PET/CT early response prediction for triple negative breast cancer neoadjuvant chemotherapy with addition of carboplatin
    Kubeczko, Marcin
    Michalik, Anna
    Badora-Rybicka, Agnieszka
    Polakiewicz-Gilowska, Anna
    d'Amico, Andrea
    Kalemba, Michal
    Lesniak, Aleksandra
    Swiderska, Katarzyna
    Mianowska-Malec, Marta
    Pasierbek, Agnieszka
    Lanoszka, Barbara
    Chomik, Konstanty
    Bobek-Billewicz, Barbara
    Jarzab, Michal
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [8] 18F-FDG PET/CT for early prediction of pathological complete response in breast cancer neoadjuvant therapy: a retrospective analysis
    Wu, Yilin
    Li, Yanling
    Chen, Bin
    Zhang, Ying
    Xing, Wanying
    Guo, Baoliang
    Wang, Wan
    [J]. ONCOLOGIST, 2024,
  • [9] FDG PET/CT for early monitoring of response to neoadjuvant chemotherapy in breast cancer patients.
    Andrade, W.
    Soares, F.
    Lima, E.
    Maciel, MdS
    Toledo, C.
    Lyeyasu, H.
    Cruz, M.
    Fanelli, M.
    [J]. CANCER RESEARCH, 2012, 72
  • [10] Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?
    Andrade, W. P.
    Lima, E. N. P.
    Osorio, C. A. B. T.
    do Socorro Maciel, M.
    Baiocchi, G.
    Bitencourt, A. G. V.
    Fanelli, M. F.
    Damascena, A. S.
    Soares, F. A.
    [J]. EJSO, 2013, 39 (12): : 1358 - 1363